Klebsiella pneumoniae

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Klebsiella pneumoniae"[MeSH Terms]

Searching Images

Klebsiella pneumoniae gram stain morphology culture

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Loading Image
Reading File
I now have comprehensive data. Let me compile the full, detailed answer.

Klebsiella pneumoniae

Classification & Microbiology

Klebsiella pneumoniae is a Gram-negative, non-motile, encapsulated, lactose-fermenting, facultatively anaerobic rod belonging to the family Enterobacteriaceae. Key microbiological features:
  • Capsule (K antigen): Large polysaccharide capsule - the organism's primary virulence factor. Blocks complement deposition and opsonophagocytosis. Gives colonies a glistening, mucoid appearance on agar. On Gram stain, a visible negative space (halo) may be seen around the rods.
  • Indole negative (unlike K. oxytoca, which is indole positive)
  • Non-motile (unlike most Enterobacteriaceae)
  • Ferments lactose (produces acid and gas)
  • Urease and ONPG positive
(Quick Compendium of Clinical Pathology 5th ed., p. 180; Sherris & Ryan's Medical Microbiology, 8th ed.)

Pathotypes

There are two clinically important pathotypes:
FeatureClassical Kp (cKp)Hypervirulent Kp (hvKp)
HostImmunocompromised, debilitatedPreviously healthy individuals
SettingHospital/healthcare-associatedCommunity-acquired
GeographyGlobalAsia, South Africa (emerging globally)
Key infectionHAP, VAP, UTI, BSIPrimary liver abscess, endophthalmitis, meningitis
Metastatic spreadRareYes - from liver abscess to eye, CNS, lungs
ResistanceHigh (ESBL, KPC)Usually susceptible (but MDR strains emerging)
String testVariableOften positive (hypermucoviscous)
Biomarkers-iucA, iroB, peg-344, rmpA, rmpA2 (all 5 = definitive)
(Harrison's Principles of Internal Medicine, 22nd ed., 2025)

Virulence Factors

  1. Polysaccharide capsule - antiphagocytic, anti-complement
  2. Lipopolysaccharide (LPS/O antigen) - endotoxin activity, serum resistance
  3. Fimbriae (type 1 and type 3) - adhesion to uroepithelium and respiratory mucosa
  4. Siderophores (in hvKp: aerobactin iucA, salmochelin iroB) - iron acquisition, greatly enhance virulence
  5. Rmp proteins (rmpA, rmpA2) - upregulate capsule production, confer hypermucoviscosity
  6. Outer membrane proteins - contribute to antibiotic resistance

Clinical Syndromes

1. Pneumonia

K. pneumoniae is the most frequent cause of Gram-negative bacterial pneumonia.
  • Classic population: Chronic alcoholics, malnourished patients, diabetics, COPD patients, debilitated elderly
  • Classic features: Lobar consolidation (often upper lobe, right side), "currant jelly sputum" (thick, blood-tinged mucoid sputum due to abundant capsular polysaccharide), "bulging fissure sign" on CXR
  • Modern presentations are often less dramatic - patchy infiltrate rather than massive lobar consolidation
  • Complications: lung abscess, empyema, pulmonary necrosis, pleural effusion
  • Hospital-acquired: ventilator-associated pneumonia (VAP) is a major concern
(Robbins, Cotran & Kumar Pathologic Basis of Disease; Robbins & Kumar Basic Pathology)

2. Urinary Tract Infection

  • cKp causes only 1-2% of UTIs in healthy adults but 5-17% of complicated UTIs (structural/functional abnormalities, catheter use)
  • hvKp more commonly presents as renal or prostatic abscess via bacteremic spread rather than ascending infection

3. Primary Liver Abscess (hvKp hallmark)

  • Characteristic of the hypervirulent pathotype, especially in Southeast Asia
  • Occurs in previously healthy, often younger individuals
  • CT shows solitary right lobe abscess
  • Metastatic spread to eye (endophthalmitis - can cause blindness), CNS, lungs, joints
  • Often requires percutaneous drainage + prolonged antibiotics

4. Bacteremia / Sepsis

  • Klebsiella bacteremia can arise from any infected site: urinary tract (15-30%), respiratory tract (15-30%), abdominal (hepatic abscess) (15-30%), intravascular device (5%)
  • Associated with high mortality in MDR strains

5. Other Infections

  • Neonatal sepsis and meningitis in LMICs
  • Wound and soft tissue infections
  • Rhinoscleroma (K. rhinoscleromatis) - chronic granulomatous nasal infection; Mikulicz cells
  • Granuloma inguinale/Donovanosis (K. granulomatis)
  • Pneumonia in severely malnourished children in low- and middle-income countries

Clinical Image - Hypervirulent K. pneumoniae

The image below (from Harrison's Principles, 22nd ed.) shows:
  • Top: Abdominal CT of a healthy 24-year-old - primary liver abscess (red arrow) with metastatic spread to the spleen (black arrow)
  • Middle: Endophthalmitis in a healthy 33-year-old
  • Bottom: Positive string test - mucoid colony stretching >5 mm with inoculating loop, indicating hypermucoviscous phenotype
hvKp - liver abscess, endophthalmitis, string test

Laboratory Diagnosis

  • Gram stain: Gram-negative rods, sometimes with visible capsular halo
  • Grows readily on standard media (blood agar, MacConkey agar - pink/lactose-fermenting)
  • Mucoid, glistening colonies; string test can be performed
  • Indole negative (K. pneumoniae sensu stricto); Urease positive
  • Definitive hvKp identification: PCR/genomic detection of all 5 biomarkers: iucA, iroB, peg-344, rmpA, rmpA2
(Harrison's Principles of Internal Medicine, 22nd ed.)

Antibiotic Resistance - Major Concern

K. pneumoniae is a WHO priority pathogen for antimicrobial resistance research.

Resistance Mechanisms

MechanismDetails
Intrinsic ampicillin resistanceChromosomal penicillinase
ESBL (Extended-Spectrum Beta-Lactamase)Most commonly CTX-M type; hydrolysis of 3rd-gen cephalosporins and penicillins; ~25% of US hospital isolates (higher in Asia, South America, Africa)
AmpC beta-lactamaseResistance to beta-lactam/beta-lactamase inhibitor combinations
KPC (K. pneumoniae Carbapenemase)Serine carbapenemase; most common carbapenemase in the US; confers resistance to virtually all beta-lactams; now found in many Enterobacteriaceae (hence renamed CRE)
MBL (Metallo-beta-lactamase)NDM-type; high prevalence in Eastern Europe, Asia; not inhibited by avibactam
OXA-48Oxacillinase-type carbapenemase
Porin loss + efflux pumpsContribute to high-level carbapenem resistance
(Quick Compendium of Clinical Pathology 5th ed.; Harrison's 22nd ed.)

Treatment by Resistance Profile

OrganismPreferred Treatment
Susceptible Kp3rd-gen cephalosporins, fluoroquinolones, TMP-SMX
ESBL-producing KpCarbapenems (meropenem, ertapenem); oral options limited
KPC-producing CRECeftazidime-avibactam, meropenem-vaborbactam, imipenem-cilastatin-relebactam
NDM-producing CRECefiderocol, aztreonam-avibactam, polymyxins (combination)
Extensively resistantConsult Infectious Diseases; combination therapy
(Harriet Lane Handbook, 23rd ed.; Harrison's 22nd ed.; Washington Manual of Medical Therapeutics)

Risk Factors for Acquisition

  • Hospitalization / LTCF residence
  • Mechanical ventilation (VAP)
  • Indwelling urinary catheter (complicated UTI)
  • Diabetes mellitus
  • Chronic alcoholism
  • COPD / structural lung disease
  • Immunosuppression (neutropenia, transplant, steroids)
  • Broad-spectrum antibiotic use (selects for MDR strains)
  • Asian origin / travel (for hvKp and NDR strains)

Epidemiology (2025 Update)

A 2025 systematic review and meta-analysis (PMID 41208438) analyzed the global prevalence of hypervirulent K. pneumoniae, highlighting that hvKp is no longer confined to Asia and is an emerging global threat - particularly as MDR and hvKp lineages increasingly converge. A 2024 systematic review (PMID 38147789) documented secondary Klebsiella infections in COVID-19 patients as a major contributor to mortality in the pandemic era.

Summary Table

FeatureDetail
Gram stainGram-negative rod
MotilityNon-motile
CapsuleLarge polysaccharide (K antigen) - mucoid colonies
IndoleNegative (K. pneumoniae); Positive (K. oxytoca)
Key infectionsPneumonia, UTI, liver abscess, bacteremia
Classic sputum"Currant jelly" (thick, blood-tinged)
Classic patientAlcoholic/diabetic/malnourished OR healthy young (hvKp)
String testPositive in hvKp (hypermucoviscous)
Key resistance genesESBL (CTX-M), KPC, NDM, OXA-48
Carbapenemase prevalence (US)~8.6% of K. pneumoniae isolates (USNHSN 2015-2017)
This is a shared conversation. Sign in to Orris to start your own chat.